A carregar...
The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer
Background. Thirty to forty percent of patients with high grade nonmuscle invasive bladder cancer (NMIBC) fail to respond to intravesical therapy with bacillus Calmette-Guerin (BCG). Interferon-α2B plus BCG has been shown to be effective in a subset of patients with NMIBC BCG refractory disease. Her...
Na minha lista:
| Publicado no: | Adv Urol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621325/ https://ncbi.nlm.nih.gov/pubmed/26550012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/656918 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|